1. Home
  2. LEU vs QURE Comparison

LEU vs QURE Comparison

Compare LEU & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centrus Energy Corp.

LEU

Centrus Energy Corp.

HOLD

Current Price

$102.88

Market Cap

3.7B

Sector

Industrials

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$23.27

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEU
QURE
Founded
1998
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.1B
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
LEU
QURE
Price
$102.88
$23.27
Analyst Decision
Buy
Strong Buy
Analyst Count
19
13
Target Price
★ $240.82
$61.24
AVG Volume (30 Days)
733.1K
★ 2.5M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 29.67
EPS
★ 1.21
N/A
Revenue
★ $193,000,000.00
$13,107,000.00
Revenue This Year
$5.37
$54.78
Revenue Next Year
$0.63
$356.14
P/E Ratio
$90.05
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$106.00
$8.73
52 Week High
$402.00
$71.50

Technical Indicators

Market Signals
Indicator
LEU
QURE
Relative Strength Index (RSI) 27.63 30.08
Support Level N/A $22.32
Resistance Level $197.89 $25.61
Average True Range (ATR) 8.17 1.24
MACD -2.58 0.71
Stochastic Oscillator 1.19 79.92

Price Performance

Historical Comparison
LEU
QURE

About LEU Centrus Energy Corp.

Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: